惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

J
Java Code Geeks
腾讯CDC
Jina AI
Jina AI
博客园 - 司徒正美
博客园 - 三生石上(FineUI控件)
Apple Machine Learning Research
Apple Machine Learning Research
GbyAI
GbyAI
WordPress大学
WordPress大学
Hugging Face - Blog
Hugging Face - Blog
T
The Blog of Author Tim Ferriss
小众软件
小众软件
M
MIT News - Artificial intelligence
MyScale Blog
MyScale Blog
D
Docker
H
Hackread – Cybersecurity News, Data Breaches, AI and More
Google DeepMind News
Google DeepMind News
月光博客
月光博客
L
LangChain Blog
F
Fortinet All Blogs
Microsoft Azure Blog
Microsoft Azure Blog
博客园 - Franky
C
Check Point Blog
U
Unit 42
人人都是产品经理
人人都是产品经理

Forbes - Healthcare

The Trump Administration Is Shifting Federal Policy On Cannabis And Psychedelics How to Prevent Domestic Violence Deaths UK Smoking Ban Highlights Debate Over The Proper Function Of Government What To Do When Someone You Love Has Cancer Psychedelic Medicine Goes Mainstream: Breakthrough or Bubble? Humana Profits Eclipse $1 Billion As Medicare Costs Ease Slightly What Are Peptides And Why Is Everyone Talking About Them? Tonsillectomy Doesn’t Lead To Illness, But Tonsillitis Just Might Does Retail Pharmacy Have A Tower Records Problem? Precision Radiation Therapy Could Offer New Hope For Hard-To-Treat Cancers Centene’s Obamacare Enrollment Drops By 2 Million After Congress Strips Subsidies RFK Jr.’s Messaging Could Be Impacting Food And Pharmaceutical Choices Over A Million Road Crash Deaths Annually Prompt $350 Million Investment Breast Cancer Screening Tool Avoids Radiation, Compression, Contrast Large Study Finds Benefits Of Doula Care On Postpartum Outcomes TrumpRx Has Signed Deals With Nearly Every Major Drugmaker. Are Prices Actually Falling? America Can’t Lower Healthcare Costs Without A Moonshot Trump’s Orders Elevate The Medical Status Of Psychedelics And Cannabis Mark Cuban’s Cost Plus Drugs, Humana Partner To Take On Employer Drug Costs Cell, Gene And Specialty Drug Costs Intensify For Health Plans U.S. Tennis Participation Continues Growth. Up 54 Percent Since 2019 New AMA Study Finds Burnout Is Decreasing Among Medical Residents And Fellows Daytime Naps May Be A Sign Of Serious Health Problems, Study Reveals New Antibody Drugs Target Disease From Within Concierge Medicine Was Built For The Few. Here’s How To Open It To The Many Burnout in Medicine Is Still Prevalent, With Emergency Medicine Leading Who Is Actually Qualified To Give Advice On Peptides And Who Isn’t What the 49ers Can Teach Leaders About Handling False And Misleading Narratives Do Older Adults Need Routine Colonoscopies Or Low Thyroid Drugs? Your Period, Your Proteins, Your Health
Gene Regulation May Control How Long We Live
William A. Haseltine · 2026-04-07 · via Forbes - Healthcare
elderly-woman-looking-off-side-with-dna-strand-background

Alternative splicing—the way cells edit gene messages—forms a second, independent layer of lifespan control across mammals, with distinctive patterns in long‑lived species, especially in the brain.

ahmadzada on Freepik

The upper limit of how long a human being can live may depend on which genes are active and how cells edit the instructions those genes produce. A recent study of mammals reveals that a process called alternative splicing varies in precise, predictable ways between short-lived and long-lived species. The finding identifies an entirely new biological axis of lifespan regulation. It operates independently of the gene expression changes that have been studied for decades, and may eventually point toward interventions for age-related disease.

The molecular machinery that determines a species’ lifespan is not fixed in a single layer of biology. It is distributed across at least two: gene activity and gene editing. The editing layer is only now coming into focus.

What Cells Do With Their Instructions

Every human gene can produce multiple versions of its protein product. The process responsible for this is called alternative splicing. After a gene is copied into a preliminary RNA message, the cell’s machinery selects which segments to keep and which to cut out before assembling the final instruction set. These segments, called exons, are the parts of a gene that actually code for pieces of the protein.

Think of them like Lego bricks, with each one representing a small section that contributes to the final build. From the same set of Legos, you might create different structures by choosing different combinations of pieces. In the same way, a cell can join different exons together to form distinct versions of a protein, known as isoforms, each with its own shape and function.

Up to 95% of human genes with multiple segments undergo this editing. The result is an expansion of protein diversity from a finite number of genes. This has long been linked to disease. Roughly 15% of hereditary conditions and cancers involve splicing errors. What remains unclear is whether splicing patterns differ systematically across species with different maximum lifespans and whether those differences carry biological meaning.

A Pattern Across 26 Species

The recent study analyzed splicing patterns across six tissues: brain, heart, kidney, liver, lung and skin. It focused on 26 mammalian species with lifespans ranging from just over 2 years to 37 years. They identified 731 splicing events whose patterns correlate with maximum lifespan. About half of long-lived species show increased exon numbers, parts of genes that code for proteins. The other half shows the opposite.

These splicing events are largely distinct from the genes whose overall expression levels correlate with lifespan. Splicing captures lifespan-related information that standard gene activity measurements miss entirely. The two layers of regulation, transcription and splicing, operate in parallel, each encoding different aspects of what makes one species long-lived and another short-lived.

In most tissues, lifespan and body mass are closely intertwined. The brain’s splicing patterns break from this constraint. It maintains a distinct splicing program tied to the species' survival time. The brain contains two to three times more lifespan-associated splicing events unique to a single tissue than any other organ. Genes involved in how brain cells communicate and change, such as those that help form connections between neurons, build nerve fibers and release chemical signals, make up over 15% of the main groups found among genes whose splicing is linked to lifespan.

What This Means For Aging

The study does not deliver a therapy. It delivers a map. The genes, pathways, and regulatory proteins it identifies constitute a network of potential targets for interventions aimed at extending healthy lifespan. The enrichment of lifespan-associated splicing in protein regions that confer molecular flexibility suggests that long-lived species may maintain their cells’ ability to adapt to stress and metabolic challenge through splicing-level fine-tuning.

For the growing population of people living into their eighties and nineties with accumulating chronic disease, this work reframes a fundamental question. Aging is not only about which genes turn on or off. It is about how cells edit the messages those genes send, and whether that editing can be guided toward the patterns that nature has already selected for longer life.